ampelosin
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2018 (NCT03606694)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05623501 | Phase 1 | Dec 1, 2022 | University of Southern California |
| NCT05280561 | N/A | Jul 25, 2021 | University of California, Los Angeles, University of Southern California |
| NCT03606694 | Phase 2 | Oct 1, 2018 | University of Guadalajara |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Southern California | Academic/Hospital | 2 | 2 | 2 | 2021 |
| University of California, Los Angeles | Academic/Hospital | 1 | 0 | 1 | 2021 |
| University of Guadalajara | Academic/Hospital | 1 | 1 | 1 | 2018 |
3 organizations
Page 1 / 1